Form D · Pharmaceuticals
Neuro-Innovators LLC
Sewickley, PA · CIK 0001960774
Offering snapshot reported Feb 18, 2025 · SEC filing
- Reported sold
- $540K Offering amount: $3.39M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 18, 2025 | Initial | $540,183 | No comparison | 6 | SEC filing |
| Jan 4, 2023 | Initial | $100,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-538417
Source: Form D, filed Feb 18, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Cochran | Director |
| Peter C. Doyle | Director, Executive |
| John Howison Schroeder | Director, Executive |
| Blynn L. Schideler | Director |
| John Howison Schroeder | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
804 Persimmon Rd.
Sewickley, PA, 15143
Phone: 412-427-0998
Sewickley, PA, 15143
Phone: 412-427-0998